SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

CCXISell

Chemocentryx, Inc.

Susan M Kanaya · EVP, CFO, Sec.

$1.0M−8.0%Aug 18
CCXISell

Chemocentryx, Inc.

Thomas J. Schall · President and CEO

$6.5M−5.0%Aug 8
CCXISell

Chemocentryx, Inc.

Susan M Kanaya · EVP, CFO, Sec.

$2.3M−17.0%Aug 8
CCXISell

Chemocentryx, Inc.

James L Tyree · Director

$502K−52.0%Aug 8
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$380K−8.0%Aug 8
CCXISell

Chemocentryx, Inc.

James L Tyree · Director

$99K−17.0%Jun 13
CCXISell

Chemocentryx, Inc.

James L Tyree · Director

$1.3M−71.0%Dec 21
CCXISell

Chemocentryx, Inc.

Vifor (International) Ltd · 10% owner

$157.7M−44.0%Oct 13
CCXIBuy

Chemocentryx, Inc.

Tausif Butt · EVP and COO

$120KMay 10
CCXISell

Chemocentryx, Inc.

Geoffrey M. Parker · Director

$1.8M−20.0%Mar 8
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$2.3M−28.0%Mar 3
CCXISell

Chemocentryx, Inc.

Thomas A. Edwards · Director

$77K−1.0%Mar 3
CCXISell

Chemocentryx, Inc.

Pui San Kwan · Principal Acctg Officer

$229K−51.0%Mar 1
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$49K−1.0%Feb 11
CCXISell

Chemocentryx, Inc.

Thomas A. Edwards · Director

$28KFeb 11
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$647K−10.0%Feb 8
CCXISell

Chemocentryx, Inc.

Pui San Kwan · Principal Acctg Officer

$218K−51.0%Feb 8
CCXISell

Chemocentryx, Inc.

Thomas A. Edwards · Director

$1.2M−14.0%Feb 4
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$92K−2.0%Jan 27
CCXISell

Chemocentryx, Inc.

Pui San Kwan · Principal Acctg Officer

$272K−56.0%Jan 27
CCXISell

Chemocentryx, Inc.

Thomas A. Edwards · Director

$1.5M−15.0%Dec 29
CCXISell

Chemocentryx, Inc.

Thomas J. Schall · President and CEO

$1.9M−1.0%Dec 16
CCXISell

Chemocentryx, Inc.

Pui San Kwan · Principal Acctg Officer

$3.4M−94.0%Dec 16
CCXISell

Chemocentryx, Inc.

Vifor (International) Ltd · 10% owner

$7.4M−1.0%Aug 3
CCXISell

Chemocentryx, Inc.

Vifor (International) Ltd · 10% owner

$8.6M−2.0%Jul 29
CCXISell

Chemocentryx, Inc.

Vifor (International) Ltd · 10% owner

$7.3M−1.0%Jul 24
CCXISell

Chemocentryx, Inc.

Vifor (International) Ltd · 10% owner

$10.6M−2.0%Jul 21
CCXISell

Chemocentryx, Inc.

Vifor (International) Ltd · 10% owner

$15.1M−3.0%Jul 16
CCXISell

Chemocentryx, Inc.

Vifor (International) Ltd · 10% owner

$14.6M−2.0%Jul 13
CCXISell

Chemocentryx, Inc.

Vifor (International) Ltd · 10% owner

$15.8M−3.0%Jul 8
CCXISell

Chemocentryx, Inc.

Vifor (International) Ltd · 10% owner

$5.0M−1.0%Jul 7
CCXISell

Chemocentryx, Inc.

Thomas J. Schall · President and CEO

$5.9M−4.0%Jun 16
CCXISell

Chemocentryx, Inc.

Susan M Kanaya · EVP, CFO, Sec.

$3.2M−20.0%Jun 16
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$2.2M−31.0%Jun 16
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$3.8M−45.0%May 26
CCXISell

Chemocentryx, Inc.

Thomas J. Schall · President and CEO

$6.2M−5.0%May 12
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$2.1M−34.0%May 12
CCXISell

Chemocentryx, Inc.

Thomas J. Schall · President and CEO

$487KMay 7
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$487K−10.0%May 7
CCXISell

Chemocentryx, Inc.

Susan M Kanaya · EVP, CFO, Sec.

$4.1M−29.0%May 6
CCXISell

Chemocentryx, Inc.

Geoffrey M. Parker · Director

$1.1M−16.0%Mar 25
CCXISell

Chemocentryx, Inc.

Thomas J. Schall · President and CEO

$2.1M−2.0%Mar 5
CCXISell

Chemocentryx, Inc.

Thomas J. Schall · President and CEO

$4.0M−3.0%Feb 21
CCXISell

Chemocentryx, Inc.

Susan M Kanaya · EVP, CFO, Sec.

$1.2M−12.0%Feb 21
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$2.1M−36.0%Feb 21
CCXISell

Chemocentryx, Inc.

Susan M Kanaya · EVP, CFO, Sec.

$2.5M−21.0%Feb 13
CCXISell

Chemocentryx, Inc.

Pui San Kwan · Principal Acctg Officer

$931K−97.0%Feb 13
CCXISell

Chemocentryx, Inc.

Markus J. Cappel · Chief Bus. Officer, Treasurer

$1.7M−33.0%Feb 10
CCXISell

Chemocentryx, Inc.

Thomas J. Schall · President and CEO

$5.4M−5.0%Feb 6
CCXISell

Chemocentryx, Inc.

Susan M Kanaya · EVP, CFO, Sec.

$4.7M−36.0%Feb 5

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.